https://www.selleckchem.com/products/abt-199.html
Objective To determine the risk profile of venous thromboembolism (VTE) and evaluate VTE prophylaxis implementation of the hospitalized cancer patients in the DissolVE 2 study. Methods The data of hospitalized cancer patients in the DissolVE 2 study were analyzed. The risk distribution of VTE, preventive measures and in-hospital VTE events of hospitalized patients with tumors were described by percentage and 95% confident interval (CI). Results A total of 1 535 cancer patients were included. According to the Padua score, 826 (53.8%) pat
Me gusta
Comentario
Compartir
